Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival - Publication - Bridge of Knowledge

Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival

Abstract

Citations

4 3

CrossRef
0

Web of Science
4 6

Scopus

Authors (5)

Aleksandra Majchrzak-Celińska
Marta Słocińska
Anna-Maria Barciszewska dr hab. n. med.
Stanisław Nowak
Wanda Baer-Dubowska

Cite as

Full text

full text is not available in portal

full content of the article see on external site open in new tab

Details

Category:: Magazine publication
Type:: Magazine publication
Published in:: JOURNAL OF APPLIED GENETICS no. 57, edition 2, pages 189 - 197,
ISSN: 1234-1983
ISSN:: 1234-1983
Publication year:: 2016
DOI:: Digital Object Identifier (open in new tab) 10.1007/s13353-015-0312-7
Verified by:: No verification

seen 23 times